Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bajetta

Showing results (91-100 of 212) with videos related to

Pageof 22
Sort By:
Tumori|January 5, 2002
Single-agent chemotherapy with vinorelbine for pretreated or metastatic squamous cell carcinoma of the esophagusP Bidoli, S C Stani, D De Candis, et al.
Tumori|April 30, 1994
Control of emesis by a low dose of ondansetron and dexamethasoneM Di Bartolomeo, E Bajetta, L Biganzoli, et al.
European Journal of Cancer|April 1, 1972
Clinical trials with bleomycin in lymphomas and in solid tumorsG Bonadonna, M De Lena, S Monfardini, et al.
International Journal of Colorectal Disease|June 9, 2004
Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabineG Brandi, M A Pantaleo, C Calabrese, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1984
A clinicopathologic study in advanced non-Hodgkin's lymphomas treated with sequential non-cross-resistant regimens: comparison of the working formulation with the Rappaport and Kiel classificationsS Monfardini, F Rilke, P Valagussa, et al.
Cancer Treatment Reviews|July 1, 1994
Hormone therapy in advanced breast carcinoma: present and future trendsE Bajetta, N Zilembo, A Di Leo, et al.
Oncology Reports|May 10, 2007
Short-term effects of pamidronate on bone turnover: can bone markers be considered predictive of the analgesic response?A Martinetti, C Ripamonti, R Miceli, et al.
The International Journal of Biological Markers|July 1, 1997
Development of a rapid and ultrasensitive RIA method for estrogen (E2, E1, E1-S) determination with selective solid phase extractionA Martinetti, E Seregni, E Bajetta, et al.
Oncology|November 1, 1995
Activity of formestane in de novo tamoxifen-resistant patients with metastatic breast cancerC Noberasco, E Bajetta, N Zilembo, et al.
Cancer|December 1, 1993
A phase II study of mitoxantrone combined with beta-interferon in unresectable hepatocellular carcinomaM Colleoni, R Buzzoni, E Bajetta, et al.
Pageof 22

Showing results (91-100 of 212) with videos related to

Sort By:
Pageof 22
Tumori|January 5, 2002
Single-agent chemotherapy with vinorelbine for pretreated or metastatic squamous cell carcinoma of the esophagusP Bidoli, S C Stani, D De Candis, et al.
Tumori|April 30, 1994
Control of emesis by a low dose of ondansetron and dexamethasoneM Di Bartolomeo, E Bajetta, L Biganzoli, et al.
European Journal of Cancer|April 1, 1972
Clinical trials with bleomycin in lymphomas and in solid tumorsG Bonadonna, M De Lena, S Monfardini, et al.
International Journal of Colorectal Disease|June 9, 2004
Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabineG Brandi, M A Pantaleo, C Calabrese, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1984
A clinicopathologic study in advanced non-Hodgkin's lymphomas treated with sequential non-cross-resistant regimens: comparison of the working formulation with the Rappaport and Kiel classificationsS Monfardini, F Rilke, P Valagussa, et al.
Cancer Treatment Reviews|July 1, 1994
Hormone therapy in advanced breast carcinoma: present and future trendsE Bajetta, N Zilembo, A Di Leo, et al.
Oncology Reports|May 10, 2007
Short-term effects of pamidronate on bone turnover: can bone markers be considered predictive of the analgesic response?A Martinetti, C Ripamonti, R Miceli, et al.
The International Journal of Biological Markers|July 1, 1997
Development of a rapid and ultrasensitive RIA method for estrogen (E2, E1, E1-S) determination with selective solid phase extractionA Martinetti, E Seregni, E Bajetta, et al.
Oncology|November 1, 1995
Activity of formestane in de novo tamoxifen-resistant patients with metastatic breast cancerC Noberasco, E Bajetta, N Zilembo, et al.
Cancer|December 1, 1993
A phase II study of mitoxantrone combined with beta-interferon in unresectable hepatocellular carcinomaM Colleoni, R Buzzoni, E Bajetta, et al.
Pageof 22